NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

HealthCare Global Enterprises’s Q3 2024-25 Latest News: Profit Grows by 125.95% YoY

[fetch_key]

Highlights

🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 18.66 % in the past year, substantial increase in net sales/revenue by 0.72 %.
🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -6.75 %, Marginal decrease of -49.15% in other income during this quarter.
🔹 Profit over the Year and quarter: Significant improvement in profitability for HealthCare Global Enterprises. Notable increase of 125.95 % in net profit Year to Year, HealthCare Global Enterprises’s profitability dropped by -62.52 % Quarter to Quarter.
🔹 EPS over the Year and quarter: EPS increased by 21.95 % Year to Year. EPS decreased by -61.24 % in previous quarter. Analysis needed for shareholder value.

This report meticulously dissects the performance of HealthCare Global Enterprises, offering a panoramic view of its operational success and challenges. It delves into a variety of financial metrics, such as revenue growth, profit margins, and shareholder returns, juxtaposed against the backdrop of broader economic conditions and sector-specific trends. The analysis further explores the investor community’s perception and expectations, which influence the stock’s volatility and potential returns. By providing a forecast based on quantitative analyses and market sentiment, the report aims to outline the potential risks and rewards, guiding investors toward making strategic, data-driven investment choices.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 469.87 Cr Rs. 553.54 Cr Rs. 557.55 Cr + 0.72 % + 18.66 %
Expenses Rs. 391.26 Cr Rs. 451.3 Cr Rs. 470.19 Cr + 4.19 % + 20.17 %
Operating Profit Rs. 78.61 Cr Rs. 102.24 Cr Rs. 87.36 Cr -14.55 % + 11.13 %
OPM % 16.73 % 18.47 % 15.67 % -2.8 % -1.06 %
Other Income Rs. 6.07 Cr Rs. 11.13 Cr Rs. 5.66 Cr -49.15 % -6.75 %
Interest Rs. 29.46 Cr Rs. 35.98 Cr Rs. 40.7 Cr + 13.12 % + 38.15 %
Depreciation Rs. 44.16 Cr Rs. 49.74 Cr Rs. 56.52 Cr + 13.63 % + 27.99 %
Profit before tax Rs. 11.06 Cr Rs. 27.65 Cr Rs. -4.2 Cr -115.19 % -137.97 %
Tax % 68.93 % 25.18 % -263.1 % -288.28 % -332.03 %
Net Profit Rs. 3.43 Cr Rs. 20.68 Cr Rs. 7.75 Cr -62.52 % + 125.95 %
EPS in Rs Rs. 0.41 Rs. 1.28 Rs. 0.49 -61.72 % + 19.51 %


Today, we’re looking at HealthCare Global Enterprises’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 18.66 %. However, it did see a marginal increase of 0.72 % from the previous quarter. Expenses ticked up slightly by 4.19 % quarter-on-quarter, aligning with the annual rise of 20.17 %. Operating profit, while up 11.13 % compared to last year, faced a quarter-on-quarter dip of -14.55 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.06 %, but a shrinkage of -2.8 % sequentially. Other income fell by -49.15 % compared to the last quarter, despite an annual decline of -6.75 %. Interest expenses surged remarkably by 13.12 % from the previous quarter, yet the year-over-year increase remains at a moderate 38.15 %. Depreciation costs climbed by 13.63 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 27.99 %. Profit before tax declined annually by -137.97 % but saw a reduction from the preceding quarter by -115.19 %.
Tax expenses as a percentage of profits decreased slightly by -332.03 % compared to last year, with a more notable quarter-on-quarter decrease of -288.28 %. Net profit rose by 125.95 % year-on-year but witnessed a -62.52 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 19.51 % but a quarterly fall of -61.72 %. In summary, HealthCare Global Enterprises’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 469.87 Cr Rs. 553.54 Cr Rs. 557.55 Cr + 0.72 % + 18.66 %
Expenses Rs. 391.26 Cr Rs. 451.3 Cr Rs. 470.19 Cr + 4.19 % + 20.17 %
Operating Profit Rs. 78.61 Cr Rs. 102.24 Cr Rs. 87.36 Cr -14.55 % + 11.13 %
Net Profit Rs. 3.43 Cr Rs. 20.68 Cr Rs. 7.75 Cr -62.52 % + 125.95 %
EPS in Rs Rs. 0.41 Rs. 1.28 Rs. 0.49 -61.72 % + 19.51 %


In reviewing HealthCare Global Enterprises’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 18.66 % year-on-year growth, however, there was a minor increase of 0.72 % from the previous quarter. Expenses rose by 20.17 % compared to the previous year, with a 4.19 % increase quarter-on-quarter. Operating Profit surged by 11.13 % annually, and saw a -14.55 % decrease from the last quarter.
Net Profit showed yearly increase of 125.95 %, and experienced a -62.52 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 19.51 % annually, however dipped by -61.72 % compared to the last quarter. In essence, while HealthCare Global Enterprises exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post